Two Generic Drug Companies Agree To Pay $305M To Settle Price Fixing, Other Claims
The United States Department of Justice announced on August 21, 2023 deferred prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, Inc. (“Teva”) and Glenmark Pharmaceuticals Inc., USA (“Glenmark”). As part of the agreements, both compa[...]